Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
9.45B | 9.49B | 10.11B | 9.39B | 7.84B | Gross Profit |
1.73B | 1.65B | 1.95B | 1.94B | 1.39B | EBIT |
338.90M | 205.60M | 535.10M | 497.00M | 61.10M | EBITDA |
614.40M | 494.50M | 780.20M | 795.70M | 267.60M | Net Income Common Stockholders |
131.30M | -35.40M | 196.40M | 250.00M | -220.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
793.30M | 767.70M | 644.50M | 770.70M | 1.07B | Total Assets |
7.55B | 7.77B | 7.95B | 7.89B | 7.34B | Total Debt |
373.50M | 3.57B | 3.60B | 3.66B | 3.68B | Net Debt |
-419.80M | 2.80B | 2.95B | 2.89B | 2.61B | Total Liabilities |
5.79B | 6.10B | 6.29B | 6.44B | 6.24B | Stockholders Equity |
1.75B | 1.68B | 1.66B | 1.45B | 1.09B |
Cash Flow | Free Cash Flow | |||
208.00M | 101.20M | -1.60M | 495.70M | -79.20M | Operating Cash Flow |
208.00M | 152.20M | 49.10M | 549.50M | -38.20M | Investing Cash Flow |
81.20M | 48.90M | -120.70M | -749.50M | -257.80M | Financing Cash Flow |
-253.40M | -120.80M | -79.30M | -65.80M | 571.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $12.44B | 23.26 | 8.08% | ― | 12.87% | 142.90% | |
74 Outperform | $41.88B | 44.38 | 11.51% | ― | 11.95% | -1.25% | |
64 Neutral | $9.21B | 41.22 | 12.21% | 0.24% | 13.08% | 146.40% | |
61 Neutral | $4.91B | 18.99 | -3.12% | 7.77% | 6.71% | -19.69% | |
58 Neutral | $2.62B | 20.44 | 7.48% | ― | -0.50% | ― | |
56 Neutral | $961.53M | 16.72 | 17.85% | 5.12% | -3.68% | 990.23% | |
44 Neutral | $195.25M | ― | -33.17% | ― | -35.03% | -101.77% |
Cushman & Wakefield announced on January 23, 2025, that they successfully repriced their Term Loan issued in June 2024, reducing the interest rate by 25 basis points to Term SOFR plus 2.75%. This financial move is part of their strategy to maintain a strong financial foundation for future growth opportunities, with all other loan terms remaining unchanged. The repricing reflects the company’s robust financial management and commitment to its stakeholders.